Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
718.00    -5.00 (-0.69%)
Bid:
719.00
Ask:
721.00
Spread: 2.00 (0.278%)
Market Cap: £690.19m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Amendment to Placing

27 Mar 2013 17:22

RNS Number : 0670B
Acal PLC
27 March 2013
Β 

ο»Ώ

Β 

Β 

27 March 2013

Β 

Acal plc

Β 

Amendment to Placing

Β 

Β 

Further to the Company's announcement on 8 March 2013 in relation to the Placing and to the announcement earlier today that shareholders had approved the Acquisition at today's General Meeting, the Company advises that the number of New Ordinary Shares to be issued pursuant to the Placing has been amended to 2,816,074 New Ordinary Shares (the "Placing Shares"), representing a reduction of 29,058 Ordinary Shares. The number of Placing Shares has been reduced in order to ensure that the Placing Shares represent less than 10 per cent of the number of Ordinary Shares currently admitted to trading of 28,188,931 Ordinary Shares. The Company's total issued share capital prior to the Placing is 28,479,804 Ordinary Shares and the Company will seek admission for the balance in due course.

Β 

The gross proceeds of the Placing will therefore reduce to Β£6.05 million from Β£6.12 million. All other terms of the Placing and the Placing Price will remain unchanged. It is expected that Admission will become effective and that dealings for normal settlement in the Placing Shares will commence on the London Stock Exchange at 8.00 a.m. on 28 March 2013.

All terms in this announcement have the meaning given to them in the announcement made by the Company at 7:00 a.m. on 8 March 2013 unless otherwise defined herein.

Β 

For further information please contact:

Acal plc
01483 544 500
Nick Jefferies

Simon Gibbins

Β 

Oriel SecuritiesSponsor, sole bookrunner and broker

020 7710 7600
David Arch
Ashton Clanfield
Stewart Wallace
Β 
Β 
Cubitt Consulting
020 7367 5100
Gareth David
Cebuan Bliss

Β 

Β 

Disclaimer:

This announcement contains a number of forward-looking statements relating to the Group and the Enlarged Group with respect to, amongst others, the following: financial condition; results of operations; economic conditions in which the Group operates and in which the Enlarged Group will operate; the business of the Group and the Enlarged Group; future benefits of the Acquisition and management plans and objectives. The Company considers any statements that are not historical facts as "forward-looking statements". They relate to events and trends that are subject to risks and uncertainties that could cause the actual results and financial position of either the Group or the Enlarged Group to differ materially from the information presented in the relevant forward-looking statement. When used in this announcement the words "estimate", "project", "intend", "aim", "anticipate", "believe", "expect", "should" and similar expressions, as they relate to the Group and/or the Enlarged Group or the management, are intended to identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Neither the Company nor any member of the Group or the Enlarged Group undertake any obligation publicly to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, save in respect of any requirement under applicable laws, the Listing Rules, the Disclosure and Transparency Rules and other regulations.

No statement in this announcement is intended as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the earnings per share of the Group or the Enlarged Group for the current or future financial periods will necessarily match or exceed the historical or published earnings per share of the Group or the Enlarged Group.

This announcement has been prepared in accordance with English law, the Listing Rules and the Disclosure and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

The Announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction in which such offer or solicitation is or may be unlawful. This announcement and the information contained herein is not for publication or distribution, directly or indirectly, to persons in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction in which such publication or distribution is unlawful. No public offer of securities of the Company is being made in the United Kingdom, United States or elsewhere.Β In particular the Placing Shares referred to in thisΒ announcement have not been and will not be registered under the Securities Act or any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any state or other jurisdiction of the United States.ThisΒ announcement has not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of thisΒ announcement. Any representation to the contrary is a criminal offence in the United States.

The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; and the Placing Shares have not been, nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of Australia, Canada, Japan or South Africa. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Australia, Canada, Japan or South Africa or any other jurisdiction outside the United Kingdom.Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of thisannouncement should seek appropriate advice before taking any action.

Apart from the liabilities and responsibilities, if any, which may be imposed on Oriel Securities Limited ("Oriel Securities") by FSMA or the regulatory regime established thereunder, Oriel Securities accepts no responsibility whatsoever for the contents of this announcement or for any other statement made or purported to be made by it or on its behalf in connection with the Company or the Acquisition. Nothing contained in this document is, or shall be relied upon as, a promise or representation by Oriel Securities as to the past, present or future. Oriel Securities disclaims all and any liability whether arising in tort or contract or otherwise (save as referred to above) which it might otherwise have in respect of this announcement or any such statement.

Oriel Securities, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Acal plc in connection with the Acquisition and will not be responsible to anyone other than Acal plc for providing the protections afforded to its clients or for providing advice in relation to the Acquisition.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCPGUWGWUPWGMM
Date   Source Headline
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings
1st Sep 202210:17 amRNSNotification of Major Holdings
26th Aug 20222:27 pmRNSNotification of Major Holdings
22nd Aug 202210:21 amRNSNotification of Major Holdings
29th Jul 20224:23 pmRNSNotification of Major Holdings
28th Jul 20223:00 pmRNSResults of Annual General Meeting
28th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSAcquisition of the CDT group
27th Jun 20223:44 pmRNSDirector / PDMR Shareholding
24th Jun 20221:00 pmRNSAnnual Report and Notice of AGM
24th Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20229:58 amRNSDirector LTIP Award
15th Jun 20228:03 amRNSNotification of Major Holdings
14th Jun 20227:00 amRNSPreliminary results
6th Jun 20227:00 amRNSNotice of Full Year Results
19th May 20222:38 pmRNSNotification of Major Holdings
11th May 20227:00 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202210:57 amRNSTR-1: Notification of Major Holdings
14th Apr 20227:00 amRNSFull Year Trading Update
7th Apr 20227:00 amRNSdiscoverIE Awarded “A” Rating by MSCI ESG
29th Mar 20224:29 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector Declaration
10th Mar 20223:02 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSHolding(s) in Company
4th Mar 20227:00 amRNSCompletion of Distribution Businesses Disposals
25th Feb 20229:50 amRNSDirector/PDMR Shareholding
9th Feb 20227:00 amRNSTrading Update
9th Feb 20227:00 amRNSChange to Operating Segments
10th Dec 20213:49 pmRNSDirector/PDMR Shareholding
8th Dec 20218:50 amRNSDirector/PDMR Shareholding
6th Dec 20218:30 amRNSIssue of Equity & Total Voting Rights
30th Nov 20217:00 amRNSInterim Results
22nd Nov 20214:05 pmRNSHolding(s) in Company
11th Nov 202112:49 pmRNSNotice of Half Year Results
9th Nov 20217:00 amRNSSale of Acal BFi Distribution Business
4th Nov 20217:00 amRNSAppointment of Non-Executive Director
14th Oct 20217:00 amRNSFirst Half Trading Update
4th Oct 20217:00 amRNSSale of Vertec SA
9th Sep 202110:44 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSResults of Placing
2nd Sep 20215:40 pmRNSAcquisitions & Proposed Placing
5th Aug 20215:30 pmRNSAggreko
30th Jul 20212:06 pmRNSDirector LTIP Award
29th Jul 20214:09 pmRNSResults of Annual General Meeting
29th Jul 20217:00 amRNSTrading Update
28th Jun 202110:09 amRNSHolding(s) in Company
25th Jun 20215:24 pmRNSDirector / PDMR Shareholding
16th Jun 202110:00 amRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.